Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Axsome Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 5.8K | Jun 7, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
AXSM | Axsome Therapeutics, Inc. | Jun 7, 2024 | 1 | $0 | 4 | Jun 11, 2024 | Director |
AXSM | Axsome Therapeutics, Inc. | Feb 27, 2024 | 1 | $0 | 4 | Feb 29, 2024 | Director |
AXSM | Axsome Therapeutics, Inc. | Jun 2, 2023 | 1 | $0 | 4 | Jun 6, 2023 | Director |
AXSM | Axsome Therapeutics, Inc. | Mar 2, 2023 | 1 | $0 | 4 | Mar 6, 2023 | Director |
AXSM | Axsome Therapeutics, Inc. | Jun 3, 2022 | 1 | $0 | 4 | Jun 7, 2022 | Director |
AXSM | Axsome Therapeutics, Inc. | Mar 4, 2022 | 1 | $0 | 4 | Mar 8, 2022 | Director |
AXSM | Axsome Therapeutics, Inc. | Nov 17, 2021 | 4 | $114K | 4 | Nov 19, 2021 | Director |
AXSM | Axsome Therapeutics, Inc. | Jun 4, 2021 | 1 | $0 | 4 | Jun 8, 2021 | Director |